Vertex Pharmaceuticals Incorporated (VRTX)
USD 478.23
(-1.19%)
USD 478.23
(-1.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.14 Billion USD | 21.51% |
| 2022 | 4.23 Billion USD | 27.18% |
| 2021 | 3.33 Billion USD | 8.73% |
| 2020 | 3.06 Billion USD | 37.25% |
| 2019 | 2.23 Billion USD | 23.34% |
| 2018 | 1.81 Billion USD | 20.42% |
| 2017 | 1.5 Billion USD | -3.34% |
| 2016 | 1.55 Billion USD | 10.77% |
| 2015 | 1.4 Billion USD | 13.24% |
| 2014 | 1.24 Billion USD | 28.83% |
| 2013 | 962.63 Million USD | -36.87% |
| 2012 | 1.52 Billion USD | 23.1% |
| 2011 | 1.23 Billion USD | 1.42% |
| 2010 | 1.22 Billion USD | 42.27% |
| 2009 | 858.55 Million USD | 15.77% |
| 2008 | 741.6 Million USD | 124.6% |
| 2007 | 330.18 Million USD | -20.56% |
| 2006 | 415.64 Million USD | 34.16% |
| 2005 | 309.82 Million USD | -39.25% |
| 2004 | 510.01 Million USD | -4.05% |
| 2003 | 531.56 Million USD | 21.6% |
| 2002 | 437.13 Million USD | -2.81% |
| 2001 | 449.78 Million USD | 16.53% |
| 2000 | 385.98 Million USD | 1563.72% |
| 1999 | 23.2 Million USD | 15.42% |
| 1998 | 20.1 Million USD | 2.55% |
| 1997 | 19.6 Million USD | 54.33% |
| 1996 | 12.7 Million USD | -7.3% |
| 1995 | 13.7 Million USD | 28.04% |
| 1994 | 10.7 Million USD | -6.96% |
| 1993 | 11.5 Million USD | 61.97% |
| 1992 | 7.1 Million USD | 44.9% |
| 1991 | 4.9 Million USD | 22.5% |
| 1990 | 4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 5.37 Billion USD | 4.29% |
| 2024 Q3 | 6.6 Billion USD | 23.37% |
| 2024 Q2 | 5.35 Billion USD | -0.25% |
| 2023 FY | 5.14 Billion USD | 21.51% |
| 2023 Q1 | 4.54 Billion USD | 7.17% |
| 2023 Q3 | 5.21 Billion USD | 6.85% |
| 2023 Q4 | 5.14 Billion USD | -1.22% |
| 2023 Q2 | 4.87 Billion USD | 7.42% |
| 2022 FY | 4.23 Billion USD | 27.18% |
| 2022 Q4 | 4.23 Billion USD | 15.27% |
| 2022 Q3 | 3.67 Billion USD | 0.77% |
| 2022 Q2 | 3.64 Billion USD | 8.95% |
| 2022 Q1 | 3.34 Billion USD | 0.5% |
| 2021 Q1 | 3.13 Billion USD | 2.28% |
| 2021 Q2 | 3.02 Billion USD | -3.49% |
| 2021 Q3 | 3.08 Billion USD | 2.07% |
| 2021 Q4 | 3.33 Billion USD | 7.92% |
| 2021 FY | 3.33 Billion USD | 8.73% |
| 2020 Q2 | 2.69 Billion USD | 10.92% |
| 2020 Q4 | 3.06 Billion USD | -3.26% |
| 2020 Q1 | 2.43 Billion USD | 8.88% |
| 2020 FY | 3.06 Billion USD | 37.25% |
| 2020 Q3 | 3.16 Billion USD | 17.46% |
| 2019 Q3 | 2.26 Billion USD | 15.16% |
| 2019 Q2 | 1.96 Billion USD | 7.9% |
| 2019 Q1 | 1.81 Billion USD | 0.5% |
| 2019 Q4 | 2.23 Billion USD | -1.24% |
| 2019 FY | 2.23 Billion USD | 23.34% |
| 2018 FY | 1.81 Billion USD | 20.42% |
| 2018 Q4 | 1.81 Billion USD | 7.37% |
| 2018 Q3 | 1.68 Billion USD | 4.06% |
| 2018 Q2 | 1.62 Billion USD | 6.46% |
| 2018 Q1 | 1.52 Billion USD | 1.23% |
| 2017 Q2 | 1.41 Billion USD | -51.87% |
| 2017 Q3 | 1.39 Billion USD | -1.64% |
| 2017 Q4 | 1.5 Billion USD | 7.79% |
| 2017 FY | 1.5 Billion USD | -3.34% |
| 2017 Q1 | 2.94 Billion USD | 89.43% |
| 2016 Q1 | 1.37 Billion USD | -2.33% |
| 2016 Q2 | 1.38 Billion USD | 0.61% |
| 2016 Q3 | 1.4 Billion USD | 1.89% |
| 2016 FY | 1.55 Billion USD | 10.77% |
| 2016 Q4 | 1.55 Billion USD | 10.62% |
| 2015 Q3 | 1.35 Billion USD | 2.37% |
| 2015 Q2 | 1.32 Billion USD | 13.49% |
| 2015 Q1 | 1.16 Billion USD | -5.79% |
| 2015 Q4 | 1.4 Billion USD | 3.47% |
| 2015 FY | 1.4 Billion USD | 13.24% |
| 2014 Q2 | 945.55 Million USD | -2.14% |
| 2014 Q4 | 1.24 Billion USD | -0.8% |
| 2014 Q1 | 966.23 Million USD | 0.37% |
| 2014 FY | 1.24 Billion USD | 28.83% |
| 2014 Q3 | 1.25 Billion USD | 32.22% |
| 2013 Q4 | 962.63 Million USD | -12.17% |
| 2013 Q1 | 1.41 Billion USD | -7.18% |
| 2013 FY | 962.63 Million USD | -36.87% |
| 2013 Q2 | 1.03 Billion USD | -26.83% |
| 2013 Q3 | 1.09 Billion USD | 5.83% |
| 2012 Q1 | 1.24 Billion USD | 0.12% |
| 2012 Q3 | 1.45 Billion USD | 6.82% |
| 2012 Q4 | 1.52 Billion USD | 4.87% |
| 2012 FY | 1.52 Billion USD | 23.1% |
| 2012 Q2 | 1.36 Billion USD | 9.75% |
| 2011 FY | 1.23 Billion USD | 1.42% |
| 2011 Q4 | 1.23 Billion USD | -8.99% |
| 2011 Q3 | 1.36 Billion USD | 13.56% |
| 2011 Q2 | 1.19 Billion USD | 4.52% |
| 2011 Q1 | 1.14 Billion USD | -6.11% |
| 2010 Q3 | 1.23 Billion USD | 49.77% |
| 2010 Q2 | 827.06 Million USD | 6.08% |
| 2010 Q1 | 779.69 Million USD | -9.25% |
| 2010 Q4 | 1.22 Billion USD | -1.39% |
| 2010 FY | 1.22 Billion USD | 42.27% |
| 2009 FY | 858.55 Million USD | 15.77% |
| 2009 Q1 | 859.03 Million USD | 15.83% |
| 2009 Q2 | 710.81 Million USD | -17.25% |
| 2009 Q3 | 964.74 Million USD | 35.72% |
| 2009 Q4 | 859.14 Million USD | -10.95% |
| 2008 Q3 | 717.66 Million USD | -1.81% |
| 2008 Q4 | 741.6 Million USD | 3.34% |
| 2008 FY | 741.6 Million USD | 124.6% |
| 2008 Q1 | 585.25 Million USD | 77.25% |
| 2008 Q2 | 730.88 Million USD | 24.88% |
| 2007 Q3 | 323.11 Million USD | -6.75% |
| 2007 FY | 330.18 Million USD | -20.56% |
| 2007 Q2 | 346.48 Million USD | 3.8% |
| 2007 Q1 | 333.79 Million USD | -19.69% |
| 2007 Q4 | 330.18 Million USD | 2.19% |
| 2006 FY | 415.64 Million USD | 34.16% |
| 2006 Q4 | 415.64 Million USD | 5.4% |
| 2006 Q2 | 450.48 Million USD | 54.41% |
| 2006 Q1 | 291.74 Million USD | -5.83% |
| 2006 Q3 | 394.34 Million USD | -12.46% |
| 2005 Q4 | 309.82 Million USD | -25.75% |
| 2005 FY | 309.82 Million USD | -39.25% |
| 2005 Q1 | 492.72 Million USD | -3.39% |
| 2005 Q2 | 473.94 Million USD | -3.81% |
| 2005 Q3 | 417.26 Million USD | -11.96% |
| 2004 FY | 510.01 Million USD | -4.05% |
| 2004 Q2 | 513.75 Million USD | 0.33% |
| 2004 Q1 | 512.09 Million USD | -3.66% |
| 2004 Q3 | 500.04 Million USD | -2.67% |
| 2004 Q4 | 510.01 Million USD | 1.99% |
| 2003 Q1 | 440.03 Million USD | 0.66% |
| 2003 FY | 531.56 Million USD | 21.6% |
| 2003 Q2 | 473.93 Million USD | 7.7% |
| 2003 Q3 | 511.39 Million USD | 7.9% |
| 2003 Q4 | 531.56 Million USD | 3.94% |
| 2002 Q4 | 437.13 Million USD | 3.38% |
| 2002 FY | 437.13 Million USD | -2.81% |
| 2002 Q3 | 422.85 Million USD | -0.22% |
| 2002 Q2 | 423.79 Million USD | -0.38% |
| 2002 Q1 | 425.4 Million USD | -5.42% |
| 2001 Q4 | 449.78 Million USD | 0.83% |
| 2001 Q3 | 446.08 Million USD | 15.72% |
| 2001 Q2 | 385.48 Million USD | 1.75% |
| 2001 Q1 | 378.83 Million USD | -1.85% |
| 2001 FY | 449.78 Million USD | 16.53% |
| 2000 FY | 385.98 Million USD | 1563.72% |
| 2000 Q1 | 195.19 Million USD | 741.35% |
| 2000 Q2 | 203.21 Million USD | 4.11% |
| 2000 Q3 | 547.95 Million USD | 169.65% |
| 2000 Q4 | 385.98 Million USD | -29.56% |
| 1999 Q2 | 20 Million USD | -0.99% |
| 1999 FY | 23.2 Million USD | 15.42% |
| 1999 Q4 | 23.2 Million USD | 26.78% |
| 1999 Q1 | 20.2 Million USD | 0.5% |
| 1999 Q3 | 18.3 Million USD | -8.5% |
| 1998 Q4 | 20.1 Million USD | 6.91% |
| 1998 FY | 20.1 Million USD | 2.55% |
| 1998 Q1 | 14.9 Million USD | -23.98% |
| 1998 Q2 | 15.6 Million USD | 4.7% |
| 1998 Q3 | 18.8 Million USD | 20.51% |
| 1997 Q2 | 14.7 Million USD | 2.08% |
| 1997 Q3 | 17.2 Million USD | 17.01% |
| 1997 Q1 | 14.4 Million USD | 13.39% |
| 1997 Q4 | 19.6 Million USD | 13.95% |
| 1997 FY | 19.6 Million USD | 54.33% |
| 1996 FY | 12.7 Million USD | -7.3% |
| 1996 Q4 | 12.7 Million USD | 29.59% |
| 1996 Q1 | 11.9 Million USD | -13.14% |
| 1996 Q2 | 12 Million USD | 0.84% |
| 1996 Q3 | 9.8 Million USD | -18.33% |
| 1995 Q4 | 13.7 Million USD | 7.87% |
| 1995 FY | 13.7 Million USD | 28.04% |
| 1995 Q1 | 10.9 Million USD | 1.87% |
| 1995 Q2 | 13.7 Million USD | 25.69% |
| 1995 Q3 | 12.7 Million USD | -7.3% |
| 1994 Q3 | 12 Million USD | 6.19% |
| 1994 Q2 | 11.3 Million USD | 20.21% |
| 1994 FY | 10.7 Million USD | -6.96% |
| 1994 Q1 | 9.4 Million USD | -18.26% |
| 1994 Q4 | 10.7 Million USD | -10.83% |
| 1993 FY | 11.5 Million USD | 61.97% |
| 1993 Q1 | 8.1 Million USD | 14.08% |
| 1993 Q2 | 8.4 Million USD | 3.7% |
| 1993 Q3 | 10.2 Million USD | 21.43% |
| 1993 Q4 | 11.5 Million USD | 12.75% |
| 1992 Q2 | 5.9 Million USD | 20.41% |
| 1992 Q1 | 4.9 Million USD | 0.0% |
| 1992 Q3 | 6.4 Million USD | 8.47% |
| 1992 Q4 | 7.1 Million USD | 10.94% |
| 1992 FY | 7.1 Million USD | 44.9% |
| 1991 Q3 | 4.6 Million USD | -2.13% |
| 1991 FY | 4.9 Million USD | 22.5% |
| 1991 Q2 | 4.7 Million USD | 0.0% |
| 1991 Q4 | 4.9 Million USD | 6.52% |
| 1990 FY | 4 Million USD | 0.0% |
| 1990 Q4 | 4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -1433.701% |
| Alkermes plc | 933.53 Million USD | -451.644% |
| Agenus Inc. | 462.29 Million USD | -1013.964% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | -27.139% |
| Aptorum Group Limited | 5.25 Million USD | -97865.697% |
| Ardelyx, Inc. | 130.76 Million USD | -3838.27% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -976.486% |
| Bicycle Therapeutics plc | 224.41 Million USD | -2194.797% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -3854.996% |
| ChromaDex Corporation | 26.5 Million USD | -19327.343% |
| Chimerix, Inc. | 19.74 Million USD | -25981.54% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -14539.631% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -6996.614% |
| CRISPR Therapeutics AG | 346.76 Million USD | -1385.085% |
| Precision BioSciences, Inc. | 140.92 Million USD | -3554.414% |
| Dyadic International, Inc. | 2.34 Million USD | -219915.714% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -31565.744% |
| Fortress Biotech, Inc. | 165.93 Million USD | -3003.43% |
| Lantern Pharma Inc. | 2.73 Million USD | -187870.721% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -7104.533% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -145839.397% |
| Incyte Corporation | 1.59 Billion USD | -223.425% |
| IO Biotech, Inc. | 17.55 Million USD | -29233.561% |
| Jaguar Health, Inc. | 45.86 Million USD | -11127.925% |
| Novavax, Inc. | 2.57 Billion USD | -100.205% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -14181.99% |
| Opthea Limited | 264.6 Million USD | -1846.249% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -3839.957% |
| ContextLogic Inc. | 206 Million USD | -2399.903% |
| MiMedx Group, Inc. | 96.33 Million USD | -5245.998% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -10623.835% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -145832.698% |
| NextCure, Inc. | 14.99 Million USD | -34238.868% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -127307.224% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -77027.452% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -10918.207% |
| Vaxcyte, Inc. | 167.44 Million USD | -2975.444% |
| PDS Biotechnology Corporation | 33.25 Million USD | -15383.867% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -2089.41% |
| Pharming Group N.V. | 244.07 Million USD | -2009.943% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -43095.773% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -3929.861% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -77841.313% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -77841.313% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -6147.255% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -77422.204% |
| Acelyrin, Inc. | 86.35 Million USD | -5863.661% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -396269.881% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -35714.73% |
| Summit Therapeutics Inc. | 125.25 Million USD | -4011.387% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -54228.516% |
| Senti Biosciences, Inc. | 52.57 Million USD | -9695.895% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -7387.678% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -3298.939% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -263182.209% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -385489.908% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -2170.315% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -54878.115% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -2164.196% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -941.397% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -47085.267% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -18619.058% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -42443.809% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -958.321% |
| Immix Biopharma, Inc. | 3.72 Million USD | -138269.163% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -13519.486% |
| MEI Pharma, Inc. | 8.35 Million USD | -61537.343% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -17648.751% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -1381.616% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -3430.428% |
| Fortress Biotech, Inc. | 165.93 Million USD | -3003.43% |
| Precigen, Inc. | 41.64 Million USD | -12266.247% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -10214.04% |
| AlloVir, Inc. | 45.01 Million USD | -11340.187% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -3851.142% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -3637.155% |
| ImmuCell Corporation | 18.81 Million USD | -27270.678% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -18144.881% |
| Onconetix, Inc. | 23.18 Million USD | -22115.715% |
| PureTech Health plc | 125.58 Million USD | -4000.714% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -57439.665% |
| Elevation Oncology, Inc. | 34.28 Million USD | -14921.877% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -210525.767% |
| Seer, Inc. | 39.36 Million USD | -12982.18% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -8228.428% |
| Innoviva, Inc. | 568.55 Million USD | -805.775% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -18813.618% |
| ESSA Pharma Inc. | 3.49 Million USD | -147244.646% |
| GlycoMimetics, Inc. | 6.9 Million USD | -74512.356% |
| GT Biopharma, Inc. | 6.63 Million USD | -77539.077% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -1847.804% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -1791.313% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -6028.817% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -52588.766% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -18854.691% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -159545.456% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -6881.17% |
| Aptose Biosciences Inc. | 15.8 Million USD | -32475.732% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -46548.066% |
| Soligenix, Inc. | 7.27 Million USD | -70688.563% |
| Century Therapeutics, Inc. | 175.94 Million USD | -2827.004% |
| Kura Oncology, Inc. | 51.66 Million USD | -9868.255% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -4146.137% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -124501.984% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -77763.818% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -1938.733% |
| Autolus Therapeutics plc | 263.9 Million USD | -1851.369% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -49029.937% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -5695.343% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -10880.618% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -1359.462% |
| GRI Bio, Inc. | 2.69 Million USD | -190845.495% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -636003.683% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -16463.636% |
| IGM Biosciences, Inc. | 220.17 Million USD | -2238.936% |
| INmune Bio, Inc. | 18.86 Million USD | -27202.513% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -1907.884% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -19229.766% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -189341.901% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -156893.366% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -8709.854% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -5255.505% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -1845.266% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -525.713% |
| Verastem, Inc. | 71.18 Million USD | -7134.389% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -10372.182% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -13249.059% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -10424.401% |
| Histogen Inc. | 5.69 Million USD | -90294.945% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -117325.076% |
| Surrozen, Inc. | 8.14 Million USD | -63126.519% |
| Organovo Holdings, Inc. | 2.74 Million USD | -187301.747% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -1640705.715% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -9058.473% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -31088.227% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -9977.295% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -622702.721% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -3963.76% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -47523.407% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -3312.972% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -197411.261% |
| Apollomics, Inc. | 14.15 Million USD | -36286.632% |
| Amarin Corporation plc | 279.58 Million USD | -1741.931% |
| Mesoblast Limited | 188.79 Million USD | -2627.677% |
| Turnstone Biologics Corp. | 14.14 Million USD | -36299.491% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -2748.53% |
| Synaptogenix, Inc. | 5.52 Million USD | -93033.717% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -77363.899% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -2927.371% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -60080.95% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -292936.333% |
| Exelixis, Inc. | 678.44 Million USD | -659.059% |
| Better Therapeutics, Inc. | 23.84 Million USD | -21499.698% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -3039.241% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -766.665% |
| NLS Pharmaceutics AG | 10.68 Million USD | -48118.18% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -317080.91% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -13129.378% |
| Gritstone bio, Inc. | 125.91 Million USD | -3989.772% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -34989.943% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -101102.151% |
| Avid Bioservices, Inc. | 275.66 Million USD | -1768.117% |
| Insmed Incorporated | 1.66 Billion USD | -209.9% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -66832.466% |
| MediWound Ltd. | 27.18 Million USD | -18842.141% |
| OmniAb, Inc. | 87.4 Million USD | -5792.22% |
| Alector, Inc. | 487.66 Million USD | -956.003% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -1176.422% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -27850.068% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -13320.374% |
| Zai Lab Limited | 240.17 Million USD | -2044.169% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -717.353% |
| Aura Biosciences, Inc. | 29.22 Million USD | -17520.009% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -5316.452% |
| Immunic, Inc. | 25.36 Million USD | -20200.378% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -7338.038% |
| Veracyte, Inc. | 93.71 Million USD | -5394.937% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -196707.167% |
| FibroGen, Inc. | 585.72 Million USD | -779.214% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -29525.496% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -788445.284% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -90958.938% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 32.738% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -62717.76% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -6029.109% |
| TG Therapeutics, Inc. | 169.08 Million USD | -2945.687% |
| Galecto, Inc. | 5.89 Million USD | -87243.962% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -62065.62% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -96.677% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -17767.601% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -40703.423% |
| XBiotech Inc. | 8.39 Million USD | -61229.046% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -34989.943% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -9583.716% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -1318.264% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -19055.632% |
| Theravance Biopharma, Inc. | 169 Million USD | -2947.147% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -323.643% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -929.083% |
| Vaxxinity, Inc. | 30.94 Million USD | -16542.322% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -429.549% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -85287.309% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -591.031% |
| NexImmune, Inc. | 5.08 Million USD | -101189.634% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -1386513.677% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -167381.449% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 27.54% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -99817.928% |
| Scopus BioPharma Inc. | 7.45 Million USD | -68983.716% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -19485.457% |
| Ainos, Inc. | 7.39 Million USD | -69546.263% |
| Pluri Inc. | 34.11 Million USD | -14996.74% |
| Prothena Corporation plc | 135.01 Million USD | -3714.186% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -2018.361% |
| Celularity Inc. | 102.92 Million USD | -4903.255% |
| Rallybio Corporation | 9.43 Million USD | -54476.092% |
| Cue Biopharma, Inc. | 24.44 Million USD | -20966.885% |
| MeiraGTx Holdings plc | 319.99 Million USD | -1509.358% |
| Omeros Corporation | 403.25 Million USD | -1177.067% |
| Humacyte, Inc. | 114.67 Million USD | -4390.7% |
| Immunocore Holdings plc | 228.15 Million USD | -2157.12% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -105536.923% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -6610.711% |
| Blueprint Medicines Corporation | 918.64 Million USD | -460.589% |
| CalciMedica, Inc. | 4.02 Million USD | -127750.05% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -29408.366% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -3240.924% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -5900.909% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -1753.826% |
| Pulmatrix, Inc. | 15.96 Million USD | -32160.853% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -32549.464% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -20829.042% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -1953.284% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -10040.194% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -325.379% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -16103.002% |
| Nutriband Inc. | 1.07 Million USD | -477211.086% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -48332.239% |
| Vor Biopharma Inc. | 59.1 Million USD | -8613.116% |
| Roivant Sciences Ltd. | 773.95 Million USD | -565.389% |
| Evogene Ltd. | 17.99 Million USD | -28525.903% |
| ProKidney Corp. | 29.21 Million USD | -17526.643% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -7054.587% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -730385.7% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -172.633% |
| CorMedix Inc. | 11.91 Million USD | -43111.982% |
| BioLineRx Ltd. | 50.7 Million USD | -10056.996% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -3345.627% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -5722.865% |
| Atai Life Sciences N.V. | 49.16 Million USD | -10375.164% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -16431.039% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -28570.527% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -4031.872% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -90982.42% |
| MediciNova, Inc. | 3.89 Million USD | -132232.773% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -28073.314% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -342252.057% |
| GeoVax Labs, Inc. | 3.51 Million USD | -146206.083% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -1196.333% |
| Biomea Fusion, Inc. | 30.69 Million USD | -16680.059% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | -89.21% |
| Mereo BioPharma Group plc | 15.96 Million USD | -32162.874% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -16405.24% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -8675.475% |
| Absci Corporation | 58.3 Million USD | -8732.67% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -26935.909% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -15962.005% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -6878.994% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -5786.629% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -15149.63% |
| Allakos Inc. | 74.79 Million USD | -6785.404% |
| Imunon, Inc. | 8.53 Million USD | -60269.78% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -22786.983% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -4385.42% |
| BioAtla, Inc. | 48.98 Million USD | -10412.8% |
| NLS Pharmaceutics AG | 10.68 Million USD | -48118.18% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -185211.263% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -3843.065% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -36127.928% |
| XOMA Corporation | 145.58 Million USD | -3437.436% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -15197.193% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -7389.638% |
| aTyr Pharma, Inc. | 31.59 Million USD | -16198.383% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -8229.91% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -11352.908% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -10539.643% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -179335.54% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -63025.627% |
| Akari Therapeutics, Plc | 4.58 Million USD | -112242.932% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -28940.559% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -212.211% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1274893.315% |
| UroGen Pharma Ltd. | 243.52 Million USD | -2014.708% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -1503.864% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -186381.689% |
| Orgenesis Inc. | 35.53 Million USD | -14392.191% |
| Entera Bio Ltd. | 1.37 Million USD | -373344.525% |
| GH Research PLC | 6.7 Million USD | -76751.216% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -75632.353% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -27254.722% |
| Xencor, Inc. | 283.55 Million USD | -1716.13% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -172383.609% |
| Replimune Group, Inc. | 113.21 Million USD | -4448.731% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -136967.572% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -4874.21% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1274893.315% |
| Portage Biotech Inc. | 4.45 Million USD | -115625.843% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -342252.057% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -22241.866% |
| OncoCyte Corporation | 49.29 Million USD | -10346.266% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -124387.376% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -645655.902% |
| Purple Biotech Ltd. | 10 Million USD | -51372.264% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -88904.494% |
| scPharmaceuticals Inc. | 57.26 Million USD | -8893.556% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -41470.805% |
| HilleVax, Inc. | 78.9 Million USD | -6426.252% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -101876.238% |
| Tharimmune, Inc. | 1.81 Million USD | -283628.346% |
| Genprex, Inc. | 3.25 Million USD | -158150.487% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -18889.638% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -98253.705% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -2499802.913% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -1436193.049% |
| OKYO Pharma Limited | 7.42 Million USD | -69296.4% |
| Savara Inc. | 37.19 Million USD | -13746.526% |
| Curis, Inc. | 57.61 Million USD | -8838.763% |
| Daré Bioscience, Inc. | 26.32 Million USD | -19458.786% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -13037.314% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -356534.349% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -24636.058% |
| BeiGene, Ltd. | 2.23 Billion USD | -130.546% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -24089.048% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -1862.599% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -24107.013% |
| Erasca, Inc. | 78.61 Million USD | -6450.992% |
| bluebird bio, Inc. | 424.62 Million USD | -1112.791% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -785826.636% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -172.468% |
| DBV Technologies S.A. | 42.8 Million USD | -11932.243% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -785826.636% |
| Moderna, Inc. | 4.57 Billion USD | -12.638% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -73521.158% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -310878.261% |
| Molecular Templates, Inc. | 31.17 Million USD | -16421.125% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -30068.717% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -775.663% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -4036.219% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -18669.545% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -14026.07% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -9156.403% |
| MacroGenics, Inc. | 154.2 Million USD | -3239.537% |
| RenovoRx, Inc. | 4.46 Million USD | -115211.24% |
| Adicet Bio, Inc. | 37.12 Million USD | -13773.384% |
| Prime Medicine, Inc. | 60.78 Million USD | -8372.853% |
| Aditxt, Inc. | 28.53 Million USD | -17949.488% |
| Adagene Inc. | 45.16 Million USD | -11301.096% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -2849801.218% |
| Quantum-Si incorporated | 26.63 Million USD | -19237.614% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -638.253% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -169165.569% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -4379.606% |
| SciSparc Ltd. | 1.59 Million USD | -322771.473% |
| Vericel Corporation | 127.7 Million USD | -3932.575% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -92440.846% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -5933.171% |
| Generation Bio Co. | 171.63 Million USD | -2900.524% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -44487.013% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -12210.966% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -1937.927% |
| Invivyd, Inc. | 51.71 Million USD | -9858.424% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -5499.008% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -79063.74% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -6721.289% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -504287.855% |
| 2seventy bio, Inc. | 310.12 Million USD | -1560.551% |
| ADMA Biologics, Inc. | 193.97 Million USD | -2554.865% |
| Clene Inc. | 38.95 Million USD | -13121.227% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -14152.401% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -1904.0% |
| GeoVax Labs, Inc. | 3.51 Million USD | -146206.083% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -2606.674% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -42181.962% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -2496.686% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -42129.475% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -10603.997% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -9645.841% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -1292.387% |
| Evaxion Biotech A/S | 17.61 Million USD | -29131.195% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -3100.045% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -3261.795% |
| Trevena, Inc. | 48.26 Million USD | -10570.507% |
| Surrozen, Inc. | 8.14 Million USD | -63126.519% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -23747.187% |
| Cingulate Inc. | 10.36 Million USD | -49604.344% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -187165.455% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -13709.396% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -143487.656% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -39061.977% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -1523.513% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -20624.375% |
| Clearmind Medicine Inc. | 3.61 Million USD | -142553.423% |
| Kronos Bio, Inc. | 54.2 Million USD | -9401.301% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -10847.006% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -22526.804% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -25557.914% |
| Statera Biopharma, Inc. | 22.67 Million USD | -22609.901% |
| ImmunityBio, Inc. | 1.09 Billion USD | -372.29% |
| Korro Bio, Inc. | 51.75 Million USD | -9850.92% |
| Kineta, Inc. | 7.22 Million USD | -71207.117% |
| BioVie Inc. | 9.7 Million USD | -52979.066% |
| Codexis, Inc. | 49.94 Million USD | -10210.736% |
| Celularity Inc. | 102.92 Million USD | -4903.255% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -5250.608% |
| Celcuity Inc. | 51.45 Million USD | -9909.315% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -1491756.753% |
| Cibus, Inc. | 206.11 Million USD | -2398.484% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -12024.308% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -19451.995% |
| IN8bio, Inc. | 8.77 Million USD | -58607.25% |
| Kodiak Sciences Inc. | 213.59 Million USD | -2311.057% |
| Annexon, Inc. | 47.11 Million USD | -10829.581% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -5651.332% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -5243.668% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -37519.987% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -97.812% |
| Eyenovia, Inc. | 19.78 Million USD | -25935.021% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -2808.079% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -66945.958% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -21269.351% |
| Arcellx, Inc. | 339.75 Million USD | -1415.753% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -43182.905% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -1997.336% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -53751.302% |
| Moolec Science SA | 13.94 Million USD | -36828.423% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -11834.093% |
| Geron Corporation | 146.12 Million USD | -3424.195% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -10091.166% |
| Royalty Pharma plc | 6.29 Billion USD | 18.225% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -12847.003% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -1749117.068% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -209217.468% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -2622.515% |
| Humacyte, Inc. | 114.67 Million USD | -4390.7% |
| Structure Therapeutics Inc. | 29.05 Million USD | -17626.753% |
| 89bio, Inc. | 59.96 Million USD | -8488.296% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -19360.379% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -430485.284% |
| Genelux Corporation | 8.42 Million USD | -61061.52% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -75013.769% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -3677.757% |
| Notable Labs, Ltd. | 4.42 Million USD | -116227.084% |
| Liquidia Corporation | 73.13 Million USD | -6941.21% |
| Mustang Bio, Inc. | 17.61 Million USD | -29128.674% |
| Immunovant, Inc. | 48.95 Million USD | -10419.457% |
| Quantum-Si incorporated | 26.63 Million USD | -19237.614% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -13316.877% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -165861.972% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -6872.286% |
| Acasti Pharma Inc. | 11.55 Million USD | -44460.007% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -22678.934% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -189341.901% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -13864.802% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -377772.123% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -84378.346% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -20636.058% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -22112.733% |
| PepGen Inc. | 34.63 Million USD | -14770.492% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -42306.126% |
| United Therapeutics Corporation | 1.18 Billion USD | -335.612% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -73637.113% |
| Solid Biosciences Inc. | 38.45 Million USD | -13290.712% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -60080.95% |
| Immuneering Corporation | 12 Million USD | -42785.141% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -1640705.715% |
| Silo Pharma, Inc. | 1.56 Million USD | -328065.325% |
| Belite Bio, Inc | 4.21 Million USD | -122193.992% |
| XOMA Corporation | 145.58 Million USD | -3437.436% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -212000.494% |
| Bionomics Limited | 10.15 Million USD | -50593.389% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -23862.589% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -22375.451% |
| uniQure N.V. | 624.01 Million USD | -725.263% |
| Cassava Sciences, Inc. | 14.19 Million USD | -36178.971% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -2849801.218% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -2926.019% |
| Forte Biosciences, Inc. | 3.66 Million USD | -140374.632% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -1976160.923% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -76227.257% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -66945.958% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -29525.496% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -48630.129% |
| Altimmune, Inc. | 16.54 Million USD | -31033.547% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -733.698% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -22375.451% |
| Compugen Ltd. | 55.77 Million USD | -9133.169% |
| Peak Bio, Inc. | 20.75 Million USD | -24714.29% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -4562.014% |
| Benitec Biopharma Inc. | 4.96 Million USD | -103684.764% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -3162.609% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -6750.507% |
| Zura Bio Limited | 21.29 Million USD | -24086.549% |
| PolyPid Ltd. | 17.46 Million USD | -29381.337% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -4481.713% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -6750.507% |
| Instil Bio, Inc. | 99.8 Million USD | -5060.069% |
| argenx SE | 444.95 Million USD | -1057.386% |
| Immunome, Inc. | 28.65 Million USD | -17869.851% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -61670.421% |
| Verona Pharma plc | 58.84 Million USD | -8652.061% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -35482.118% |
| Shattuck Labs, Inc. | 14.85 Million USD | -34557.783% |
| CervoMed Inc. | 2.59 Million USD | -198293.757% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -105558.597% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -40334.987% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -48782.772% |
| Moolec Science SA | 13.94 Million USD | -36828.423% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -219647.865% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -9163.014% |
| AnaptysBio, Inc. | 364.28 Million USD | -1313.669% |
| Design Therapeutics, Inc. | 11.95 Million USD | -42972.934% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -40500.757% |
| NeurAxis, Inc. | 1.91 Million USD | -269136.942% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -13129.038% |
| Lumos Pharma, Inc. | 13.33 Million USD | -38524.466% |
| Achilles Therapeutics plc | 19.08 Million USD | -26880.667% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -35482.118% |
| 180 Life Sciences Corp. | 5.38 Million USD | -95493.098% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -21732.297% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -22526.804% |
| Nutriband Inc. | 1.07 Million USD | -477211.086% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -16730.512% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -35388.939% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -1183.362% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -15758.713% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -39364.803% |
| Palisade Bio, Inc. | 2.73 Million USD | -187917.525% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -97935.408% |
| Beam Therapeutics Inc. | 478.38 Million USD | -976.497% |
| Neurogene Inc. | 36.54 Million USD | -13990.126% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -1194.079% |
| AEON Biopharma, Inc. | 159.88 Million USD | -3120.859% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -10707.555% |
| Sesen Bio, Inc. | 30.98 Million USD | -16520.837% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -19736.678% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -67640.775% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -2530.966% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -2581.391% |
| Athira Pharma, Inc. | 30.05 Million USD | -17033.446% |
| Vaccinex, Inc. | 5.94 Million USD | -86567.789% |
| HCW Biologics Inc. | 15.05 Million USD | -34113.523% |
| XOMA Corporation | 145.58 Million USD | -3437.436% |
| Nektar Therapeutics | 267.04 Million USD | -1828.432% |
| Arvinas, Inc. | 644.6 Million USD | -698.914% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -28940.559% |
| Merus N.V. | 102.15 Million USD | -4941.36% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -3418.825% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -5314.003% |
| Rezolute, Inc. | 11.73 Million USD | -43787.847% |
| Clene Inc. | 38.95 Million USD | -13121.227% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -180761.002% |
| BeyondSpring Inc. | 48.26 Million USD | -10568.959% |
| Synlogic, Inc. | 32.89 Million USD | -15555.267% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -35141.224% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -315065.239% |
| Peak Bio, Inc. | 20.75 Million USD | -24714.29% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -8015.161% |
| Krystal Biotech, Inc. | 39.71 Million USD | -12867.216% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -1267.286% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -5072.092% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -1189983.332% |
| MannKind Corporation | 721.36 Million USD | -613.896% |
| Ikena Oncology, Inc. | 22.33 Million USD | -22957.085% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -246774.401% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -4919.788% |
| Gossamer Bio, Inc. | 249.14 Million USD | -1966.973% |
| CohBar, Inc. | 1.03 Million USD | -498120.847% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -48078.501% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -26935.909% |
| Legend Biotech Corporation | 589.93 Million USD | -772.947% |
| Mural Oncology plc | 37.92 Million USD | -13477.832% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -3782.656% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -224259.7% |
| Disc Medicine, Inc. | 22.87 Million USD | -22412.787% |
| Champions Oncology, Inc. | 28.03 Million USD | -18269.181% |
| REGENXBIO Inc. | 262.22 Million USD | -1863.864% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -153197.422% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -40986.644% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -38240.85% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -24185.782% |
| Vaxart, Inc. | 34.02 Million USD | -15035.342% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -25157.41% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -17949.283% |
| Cellectis S.A. | 249.57 Million USD | -1963.428% |
| Longeveron Inc. | 5.33 Million USD | -96392.411% |
| Repare Therapeutics Inc. | 41.81 Million USD | -12214.498% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -114.108% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -8430.679% |
| Revolution Medicines, Inc. | 262.39 Million USD | -1862.599% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -244313.859% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -59600.904% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -43538.675% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -36571.651% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -239314.226% |
| Denali Therapeutics Inc. | 122.96 Million USD | -4088.089% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -92440.846% |
| Veru Inc. | 32.81 Million USD | -15594.53% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -74871.612% |
| Cingulate Inc. | 10.36 Million USD | -49604.344% |
| Passage Bio, Inc. | 39.26 Million USD | -13016.499% |
| Context Therapeutics Inc. | 4.19 Million USD | -122756.635% |
| Exicure, Inc. | 8.54 Million USD | -60138.624% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -17352.216% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -49011.196% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -23264.639% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -3059.658% |
| Nuvalent, Inc. | 31.82 Million USD | -16082.635% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -80850.989% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -8071.432% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -28510.0% |
| OmniAb, Inc. | 87.4 Million USD | -5792.22% |
| Anew Medical, Inc. | 8.24 Million USD | -62383.931% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -13349.783% |
| Lipocine Inc. | 2.63 Million USD | -195588.678% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -19501.857% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -12706.625% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -19229.766% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -5877.436% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -95249.009% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -6123.549% |
| Ocugen, Inc. | 23.98 Million USD | -21372.71% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -10997.033% |
| Q32 Bio Inc. | 233.12 Million USD | -2109.001% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -56703.441% |
| Alumis Inc. Common Stock | 53.5 Million USD | -9525.435% |
| Equillium, Inc. | 27.95 Million USD | -18320.431% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -2392.739% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -91424.909% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -83869.132% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -3173.331% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -7316.934% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -51531.203% |
| Dominari Holdings Inc. | 4.63 Million USD | -111006.796% |
| Edesa Biotech, Inc. | 1.84 Million USD | -279531.654% |
| vTv Therapeutics Inc. | 29.56 Million USD | -17317.391% |
| Bio-Techne Corporation | 744.34 Million USD | -591.861% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -3983.934% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -1395.053% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -12592.052% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -17684.301% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -5475.79% |
| Nkarta, Inc. | 105.6 Million USD | -4776.705% |
| BioCardia, Inc. | 4.59 Million USD | -112096.078% |
| Iterum Therapeutics plc | 32.66 Million USD | -15666.946% |